Close Menu

NEW YORK (GenomeWeb) – A high-throughput, modular, and scalable, molecular diagnostics solution from Becton Dickinson has received CE-IVD certification and is now available for sale in Europe, BD announced today.

The BD Cor will be initially available with the firm's BD Onclarity HPV assay that detects and genotypes 14 high-risk human papillomaviruses. The Cor system enables processing of HPV tests directly from liquid-based cytology tubes, replacing manual aliquot steps.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.